IL10 and breast cancer: The results of animal experiments suggested that RRTS can inhibit activation of the JAK2/STAT3 inflammatory pathway, affect the expression levels of inflammatory factors TNF-α, IL-6, and IL-10 in the blood circulation, and reduce the inflammatory response in BC model mice, thereby inhibiting the malignant progression of BC.